COMPARATIVE STUDY OF THE PREVALENCE OF IGE REACTIVITY TO RECOMBINANT ALLERGENS ON THE BACKGROUND OF ALLERGEN-SPECIFIC IMMUNOTHERAPY

2020

Closed access Metadata (CSL-JSON)
DOI 10.52571/ptq.v17.n35.2020.52_saltabayeva_pgs_609_620.pdf
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

As doenas alrgicas so um dos problemas mais prementes da medicina prtica. Segundo estatsticas da Organizao Mundial da Sade, cerca de 40% da populao mundial sofre de alergias. Atualmente, o diagnstico de alergia molecular (AM) o mtodo mais til para selecionar os pacientes para prescrever imunoterapia com o objetivo de tratar alergias (imunoterapia com alrgenos), determinar a reatividade cruzada e a gravidade da reao associada a vrios alrgenos